ATMI INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 38 rows in 2013. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2013-12-31: Reporting owner Dubois Lawrence H; Form 4; Security Non-Qualified Stock Option(Right To Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2013-12-19: Reporting owner ADLEY MARK; Form 4; Security Non-Qualified Stock Option(Right To Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2013-12-16: Reporting owner BANUCCI EUGENE G; Form 4; Security Non-Qualified Stock Option(Right To Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2013-11-21: Reporting owner Mincieli Kathleen G; Form 4; Security Non-Qualified Stock Option(Right To Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2013-12-31 | Dubois Lawrence H Officer (SVP, CTO) | 4 | Non-Qualified Stock Option(Right To Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −14,248 0 owned after | $13.82 exercise price | 2014-01-02 | |
| 2013-12-19 | ADLEY MARK Director | 4 | Non-Qualified Stock Option(Right To Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,077 0 owned after | $23.40 exercise price | 2013-12-20 | |
| 2013-12-16 | BANUCCI EUGENE G Director | 4 | Non-Qualified Stock Option(Right To Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −38,893 0 owned after | $23.40 exercise price | 2013-12-17 | |
| 2013-11-21 | Mincieli Kathleen G Officer (SVP, Human Resources) | 4 | Non-Qualified Stock Option(Right To Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,750 0 owned after | $23.40 exercise price | 2013-11-25 | |
| 2013-11-14 | Carlson Timothy C Officer (EVP, CFO and Treasurer) | 4/A | Non-Qualified Stock Option(Right To Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,500 0 owned after | $23.40 exercise price | 2013-11-26 | |
| 2013-11-14 | NEUGOLD DOUGLAS A Officer (Chairman, President and CEO) | 4/A | Non-Qualified Stock Option(Right To Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −29,169 0 owned after | $23.40 exercise price | 2013-11-26 | |
| 2013-11-14 | SHARKEY DANIEL P Officer (EVP, Business Development) | 4/A | Non-Qualified Stock Option(Right To Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −19,446 0 owned after | $23.40 exercise price | 2013-11-26 | |
| 2013-11-14 | SHARKEY DANIEL P Officer (EVP, Business Development) | 4 | Non-Qualified Stock Option(Right To Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −19,446 0 owned after | $23.40 exercise price | 2013-11-18 | |
| 2013-11-14 | NEUGOLD DOUGLAS A Officer (Chairman, President and CEO) | 4 | Non-Qualified Stock Option(Right To Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −29,169 0 owned after | $23.40 exercise price | 2013-11-18 | |
| 2013-11-14 | Carlson Timothy C Officer (EVP, CFO and Treasurer) | 4 | Non-Qualified Stock Option(Right To Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,500 0 owned after | $23.40 exercise price | 2013-11-18 | |
| 2013-11-07 | Philips Mario Officer (SVP and GM, LifeSciences) | 4/A | Non-Qualified Stock Option(Right To Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 0 owned after | $23.40 exercise price | 2013-11-26 | |
| 2013-11-07 | Philips Mario Officer (SVP and GM, LifeSciences) | 4 | Non-Qualified Stock Option(Right To Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 0 owned after | $23.40 exercise price | 2013-11-12 | |
| 2013-11-06 | MARSH C DOUGLAS Director | 4 | Non-Qualified Stock Option(Right To Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,077 0 owned after | $23.40 exercise price | 2013-11-08 | |
| 2013-10-29 | MAHLE STEPHEN H Director | 4 | Non-Qualified Stock Option(Right To Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,077 0 owned after | $23.40 exercise price | 2013-10-31 | |
| 2013-08-19 | Shima Patrick J Officer (SVP and CLO) | 4 | Non-Qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,371 3,371 owned after | $24.51 exercise price | 2013-08-20 | |
| 2013-07-30 | NEUGOLD DOUGLAS A Officer (Chairman, President and CEO) | 4 | Non-Qualified Stock Option(right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 24,921 owned after | $13.82 exercise price | 2013-07-31 | |
| 2013-07-30 | Ward David M Officer (VP, Controller and PAO) | 4 | Non-Qualified Stock Option(right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 0 owned after | $23.40 exercise price | 2013-07-31 | |
| 2013-07-30 | Ward David M Officer (VP, Controller and PAO) | 4 | Non-Qualified Stock Option(right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 0 owned after | $21.87 exercise price | 2013-07-31 | |
| 2013-05-22 | SEGALL MARK B Director | 4 | Non-Qualified Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,960 2,960 owned after | $23.12 exercise price | 2013-05-24 | |
| 2013-05-17 | ADLEY MARK Director | 4 | Non-qualified Stock Option(right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +2,917 0 owned after | $19.83 exercise price | 2013-05-20 | |
| 2013-05-03 | SHARKEY DANIEL P Officer (EVP, Business Development) | 4 | Non-qualified stock options(right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,466 0 owned after | $13.82 exercise price | 2013-05-06 | |
| 2013-03-01 | NEUGOLD DOUGLAS A Officer (Chairman, President and CEO) | 4 | Non-Qualified Stock Option(right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 44,921 owned after | $13.82 exercise price | 2013-03-04 | |
| 2013-02-14 | Dubois Lawrence H Officer (SVP, CTO) | 4 | Non-Qualified Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +11,633 11,633 owned after | $21.85 exercise price | 2013-02-15 | |
| 2013-02-14 | NEUGOLD DOUGLAS A Officer (Chairman, President and CEO) | 4 | Non-Qualified Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +54,992 54,992 owned after | $21.85 exercise price | 2013-02-15 | |
| 2013-02-14 | Mincieli Kathleen G Officer (SVP, Human Resources) | 4 | Non-Qualified Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,460 8,460 owned after | $21.85 exercise price | 2013-02-15 | |
| 2013-02-14 | Philips Mario Officer (SVP and GM, LifeSciences) | 4 | Non-Qualified Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,460 8,460 owned after | $21.85 exercise price | 2013-02-15 | |
| 2013-02-14 | SHARKEY DANIEL P Officer (EVP, Business Development) | 4 | Non-Qualified Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,709 16,709 owned after | $21.85 exercise price | 2013-02-15 | |
| 2013-02-14 | Carlson Timothy C Officer (EVP, CFO and Treasurer) | 4 | Non-Qualified Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +21,574 21,574 owned after | $21.85 exercise price | 2013-02-15 | |
| 2013-02-14 | Kramer Christian Officer (SVP and GM, Microelectronics) | 4 | Non-Qualified Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,920 16,920 owned after | $21.85 exercise price | 2013-02-15 | |
| 2013-02-14 | SHAVERS CHERYL L Director | 4 | Non-Qualified Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,076 5,076 owned after | $21.85 exercise price | 2013-02-15 | |
| 2013-02-14 | SCALISE GEORGE Director | 4 | Non-Qualified Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,076 5,076 owned after | $21.85 exercise price | 2013-02-15 | |
| 2013-02-14 | MARSH C DOUGLAS Director | 4 | Non-Qualified Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,076 5,076 owned after | $21.85 exercise price | 2013-02-15 | |
| 2013-02-14 | MAHLE STEPHEN H Director | 4 | Non-Qualified Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,076 5,076 owned after | $21.85 exercise price | 2013-02-15 | |
| 2013-02-14 | HILLAS ROBERT S Director | 4 | Non-Qualified Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,076 5,076 owned after | $21.85 exercise price | 2013-02-15 | |
| 2013-02-14 | BANUCCI EUGENE G Director | 4 | Non-Qualified Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,076 5,076 owned after | $21.85 exercise price | 2013-02-15 | |
| 2013-02-14 | ADLEY MARK Director | 4 | Non-Qualified Stock Option(right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,076 5,076 owned after | $21.85 exercise price | 2013-02-15 | |
| 2013-02-11 | Ward David M Officer (VP, Controller and PAO) | 4 | Non-Qualified Stock Option(right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −500 0 owned after | $18.80 exercise price | 2013-02-11 | |
| 2013-02-11 | Philips Mario Officer (SVP and GM, LifeSciences) | 4 | Non-Qualified Stock Option(right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 0 owned after | $18.80 exercise price | 2013-02-11 |